Re:EU Commission to end AstraZeneca and J&J vaccine contract...
by selectodude on Wednesday April 14, 2021 @12:23PM
(#26809272)
J&J and AZ adenovirus-vector covid vaccines are highly novel vaccines that are very similar to mRNA vaccines, just with a different delivery mechanism.
[ Parent
| on HN ]
Re:EU Commission to end AstraZeneca and J&J vaccine contract...
by hef19898 on Wednesday April 14, 2021 @01:05PM
(#26809901)
Adeno virus based vector vaccines are a pretty old idea.
Re:EU Commission to end AstraZeneca and J&J vaccine contract...
by Imnimo on Wednesday April 14, 2021 @01:45PM
(#26810498)
I was under the impression that adenovirus vaccines have only been been approved in the past year or two - a few for Ebola and the new ones for Covid. Are there others that have been around before that?
It doesn't seem like it really matters if adenovirus vector vaccines is an "old idea" - after all, the idea of using MRNA has also been around for a long time. But if we've only started actually using them recently, how different is our knowledge of long-term effects?
Re:EU Commission to end AstraZeneca and J&J vaccine contract...
by hef19898 on Wednesday April 14, 2021 @02:19PM
(#26810962)
They are tested and researched since at least 2004. Not for Covid-19 of course.
Re:EU Commission to end AstraZeneca and J&J vaccine contract...
by saurik on Wednesday April 14, 2021 @11:31PM
(#26815939)
And mRNA vaccines were first tested in the 90s and started getting more substantial research in 2008: the timelines seem similar?
Re:EU Commission to end AstraZeneca and J&J vaccine contract...
by JamisonM on Wednesday April 14, 2021 @02:19PM
(#26810960)
Your impression is correct.
The fact that it is an "old idea" is indeed unimportant, but what is very, very important is that large scale study over long periods has already been performed on that vaccination platform so we really do know a lot about it.
That means that the similarity to mRNA is a good thing in terms of any worries about unexpected consequences. Of course it also means that we know that the risk of any unexpected consequences for adenovirus vaccines is also very low.